48
Participants
Start Date
February 28, 2009
Primary Completion Date
April 30, 2009
NRL001
Four single doses of NRL001 or placebo. NRL001 is administered at lower (5, 7.5 and 10 mg) or higher (10, 12.5 and 15 mg) doses in a slow release rectal suppository weighing either 1 g or 2 g.
Bio-Kinetic Europe Limited, Belfast
Lead Sponsor
Norgine
INDUSTRY